Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Anti-Human TGFa/TGF-alpha Antibody (LY3016859)

Catalog #:   DHB91501 Specific References (41) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Overview

Catalog No.

DHB91501

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

ETGF, Protransforming growth factor alpha, TGF type 1, TGFA, EGF-like TGF, TGF-alpha

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P01135

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

LY3016859

Data Image
  • SDS-PAGE
    SDS PAGE for LY3016859
References

An antibody-drug conjugate targeting soluble and membrane-bound TGFα is effective against pancreatic tumors., PMID:40410803

Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma., PMID:35973929

Identification of Growth Factors, Cytokines and Mediators Regulated by Artemisia annua L. Polyphenols (pKAL) in HCT116 Colorectal Cancer Cells: TGF-β1 and NGF-β Attenuate pKAL-Induced Anticancer Effects via NF-κB p65 Upregulation., PMID:35163520

Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals., PMID:34603283

Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma., PMID:34399807

Menetrier's disease. A diagnostic and therapeutic challenge., PMID:34137712

Ovarian cancer cells direct monocyte differentiation through a non-canonical pathway., PMID:33069212

The epigenetic treatment remodel genome-wide histone H4 hyper-acetylation patterns and affect signaling pathways in acute promyelocytic leukemia cells., PMID:33045196

The dichotomous role of epiregulin in pain., PMID:31917773

Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins., PMID:31711925

Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies., PMID:31052457

Mesothelin and TGF-α predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib., PMID:30921351

HER2 Activation Factors in Arsenite-Exposed Bladder Epithelial Cells., PMID:30137596

Elevated serum eosinophil cationic protein and transforming growth factor-α levels in a patient with pemphigus vegetans., PMID:29862541

Evaluation of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy After Single and Multiple Dosings of LY3016859 in Healthy Subjects and Patients With Diabetic Nephropathy., PMID:29385323

Role of TGF-alpha in the progression of diabetic kidney disease., PMID:28249836

MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression., PMID:27207663

Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers., PMID:26700622

Formation of vascular network structures within cardiac cell sheets from mouse embryonic stem cells., PMID:31245454

Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)., PMID:25520391

Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-α and epiregulin., PMID:24518034

Infliximab restores the dysfunctional matrix remodeling protein and growth factor gene expression in patients with inflammatory bowel disease., PMID:24378596

44-plex cytokine profile of cholesteatoma., PMID:24256045

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes., PMID:23374602

[Expressions of receptor tyrosine kinases mRNA and protein in carcinoma of bladder]., PMID:21906447

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6., PMID:20047592

Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice., PMID:19650867

Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma., PMID:19321179

[Connective tissue growth factors, CTGF and Cyr61 in drug-induced gingival overgrowth--an animal model]., PMID:20209781

TGF alpha has low protein expression in nonsyndromic clefts., PMID:17993868

Tumor necrosis factor regulation of apoptosis in mouse preimplantation embryos and its antagonism by transforming growth factor alpha/phosphatidylionsitol 3-kinase signaling system., PMID:17182889

Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells., PMID:16424019

Survivin contributes to the anti-apoptotic activities of transforming growth factor alpha in mouse blastocysts through phosphatidylinositol 3'-kinase pathway., PMID:16079309

Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells., PMID:15967120

Ionizing radiation-induced mitogen-activated protein (MAP) kinase activation in DU145 prostate carcinoma cells: MAP kinase inhibition enhances radiation-induced cell killing and G2/M-phase arrest., PMID:10760996

The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the epidermal growth factor receptor family of tyrosine kinases., PMID:10495354

Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy., PMID:10096554

EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5., PMID:9664130

Epidermal growth factor receptor (EGFR) in oral squamous cell carcinomas: overexpression, localization and therapeutic implications., PMID:9495132

Differential expression of transforming growth factor alpha, adhesions molecules and integrins in primary, metastatic liver tumors and in liver cirrhosis., PMID:7539239

p53 overexpression correlates with increased survival in patients with squamous carcinoma of the tongue base., PMID:1463117

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Anti-Human TGFa/TGF-alpha Antibody (LY3016859) [DHB91501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only